INVESTOR LOGIN

LRG BayStar Capital Funds Portfolio

PORTFOLIO COMPANIES

Please find some the portfolio of current and prior LRG BayStar Capital Funds' portfolio companies below:

Camitro Corporation

Camitro Corporation

Acquired by ArQule, Inc. in January 2001, Camitro is developing and commercializing an innovative, fully integrated platform of predictive computational models and data that will enable drug discovery scientists to design and select drug candidates with optimal therapeutic properties.
 

Cellomics, Inc.

Cellomics, Inc.

The leading company in creating new cellular knowledge, Cellomics' cell-based products and services enable drug discovery firms to rapidly narrow their search to include only those compounds most likely to succeed in clinical trials.
 
 
http://www.cellomics.com

Cerus Corporation (CERS)

Cerus Corporation (CERS)

Cerus develops and commercializes new technologies that improve the quality and safety of the world¹s blood supply through the decontamination of the primary blood components ¬ platelets, plasma and red blood cells.
 
 
http://www.cerus.com

CombiMatrix Corporation (CBMX)

CombiMatrix Corporation (CBMX)

CombiMatrix Corporation is a life sciences technology company with a proprietary system for rapid, cost-competitive creation of DNA and other compounds on a programmable semiconductor chip.
  http://www.combimatrix.com

Connetics Corporation (Acquired in 2006 by Stiefel Laboratories)

Connetics Corporation (Acquired in 2006 by Stiefel Laboratories)

Connetics is a biopharmaceutical company focused on the development of recombinant human relaxin for multiple indications and on the development and commercialization of novel therapeutics for dermatology and specialty medical markets.
 

 
Arque Capital
This website is for general informational purposes only and is not intended as a solicitation or offering for any investment product or service.
LRG Capital Group, in alliance with Arque Capital, Ltd. Member FINRA/SIPC